Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | protein tyrosine phosphatase non-receptor type nt1 | 0.0341 | 0.7193 | 0.7478 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0404 | 1 | 0.5 |
Echinococcus granulosus | insulin receptor | 0.0396 | 0.9619 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0396 | 0.9619 | 1 |
Echinococcus multilocularis | vesicular acetylcholine transporter | 0.0243 | 0.2899 | 0.2911 |
Schistosoma mansoni | tyrosine kinase | 0.0396 | 0.9619 | 1 |
Brugia malayi | vesicular acetylcholine transporter unc-17 | 0.0243 | 0.2899 | 0.2798 |
Schistosoma mansoni | tyrosine kinase | 0.018 | 0.014 | 0.0146 |
Schistosoma mansoni | tyrosine kinase | 0.018 | 0.014 | 0.0146 |
Loa Loa (eye worm) | vesicular acetylcholine transporter unc-17 | 0.0243 | 0.2899 | 0.2798 |
Echinococcus multilocularis | insulin receptor | 0.0396 | 0.9619 | 1 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0396 | 0.9619 | 0.9614 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0396 | 0.9619 | 1 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0404 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0404 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.018 | 0.014 | 0.0146 |
Brugia malayi | Protein kinase domain containing protein | 0.0396 | 0.9619 | 0.9614 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0396 | 0.9619 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0216 | 0.1709 | 0.1591 |
Loa Loa (eye worm) | hypothetical protein | 0.0207 | 0.1313 | 0.1189 |
Echinococcus multilocularis | tyrosine protein phosphatase non receptor type | 0.0341 | 0.7193 | 0.744 |
Echinococcus granulosus | tyrosine protein phosphatase non receptor type | 0.0341 | 0.7193 | 0.744 |
Onchocerca volvulus | Vesicular acetylcholine transporter homolog | 0.0243 | 0.2899 | 0.5 |
Loa Loa (eye worm) | protein-tyrosine phosphatase | 0.0341 | 0.7193 | 0.7153 |
Brugia malayi | Protein-tyrosine phosphatase containing protein | 0.0341 | 0.7193 | 0.7153 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0404 | 1 | 0.5 |
Schistosoma mansoni | vesicular acetylcholine transporter | 0.0243 | 0.2899 | 0.3014 |
Brugia malayi | Protein kinase domain containing protein | 0.0219 | 0.185 | 0.1734 |
Echinococcus granulosus | vesicular acetylcholine transporter | 0.0243 | 0.2899 | 0.2911 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 0 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 1.5 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 1.99 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 2.08 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 5 % | GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM. | ChEMBL. | 20485427 |
Inhibition (functional) | = 88 % | GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 89 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition frequency index (IFI) (functional) | = 2.44 | Inhibition Frequency Index (IFI) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 0 % | Percent inhibition of P. falciparum lactate dehydrogenase activity (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 5 % | Percent inhibition of HepG2 growth (at 10 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 88 % | Percent inhibition of P. falciparum Dd2 growth (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 89 % | Percent inhibition of P. falciparum 3D7 growth (at 2 uM) | GSK. | 20485427 |
XC50 (functional) | = 6.04 | XC50 determination of P. falciparum 3D7 growth | GSK. | 20485427 |
XC50 (functional) | = 0.9118 uM | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth. | ChEMBL. | 20485427 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.